Nasal virus infection induces asthma exacerbation through B‐cell‐dependent recruitment of inflammatory monocytes
International Forum of Allergy & Rhinology · 2024
DOI: 10.1002/alr.23426 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Forum of Allergy & Rhinology, 2024. Verfasst von Kody A Waldstein und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA. Hauptthemen laut MEDLINE: Monocytes, Asthma, B-Lymphocytes, Disease Models, Animal. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Background
Upper respiratory viral infections (URVIs) are responsible for 80% of asthma exacerbation episodes. However, the underlying mechanisms remain poorly understood.
Methods
In this study, we used a mouse model of URVI and examined the impact of URVI on asthma phenotypes and the underlying mechanisms.
Results
Previously, we have reported that nasal‐restricted infection with respiratory syncytial virus (RSV) only produces mild sino‐nasal inflammation and mucus production, without causing direct lung infection. However, such nasal‐restricted infection dramatically enhanced T H 2 and T H 17 inflammatory responses in the lungs and increased airway hyperresponsiveness (AHR) in mice with house dust mite (HDM)‐induced asthma. Additionally, nasal‐restricted infection with RSV recruited Ly6C+ inflammatory monocytes (IMs) into the lungs of mice with and without HDM‐induced asthma. The expression of monocyte chemokines, including CCL2 and CCL7, also increased. Interestingly, nasal virus infection‐induced AHR was abolished in mice depleted of IMs and in CCR2 −/− mice, indicating that the recruited IMs play a key role in nasal virus infection‐induced asthma exacerbations in mice. Lastly, we observed that recruitment of Ly6C+ IMs following URVI was abolished in mice lacking B cells and that nasal‐restricted infection with RSV increased numbers of CCL2+CCL7+ B cells in the lungs of mice as compared to controls.
Conclusions
Taken together, our data have shown that URVI enhances the allergic inflammatory response and AHR through a B cell‒monocyte regulatory axis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, University of Iowa, Iowa City, Iowa, USA.
- Department of Otorhinolaryngology-Head and Neck Surgery, University of Texas Health Science Center at Houston, Houston, Texas, USA.
- Department of Medicine, Division of Pulmonary Diseases and Critical Care Medicine and the Marsico Lung Institute, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
ORCID-Profile: Kody A Waldstein, Xiaoyang Hua
Förderung
- NIAID NIH HHS
- NCATS NIH HHS
- NHLBI NIH HHS
- National Institutes of Health
- University of Iowa
Zitieren
APA
Waldstein, K. A., Issimov, A., Ganama, M., Jinge, V., Tilley, S., & Hua, X. (2024). Nasal virus infection induces asthma exacerbation through B‐cell‐dependent recruitment of inflammatory monocytes. International Forum of Allergy & Rhinology. https://doi.org/10.1002/alr.23426
Vancouver
Waldstein KA, Issimov A, Ganama M, Jinge V, Tilley S, Hua X. Nasal virus infection induces asthma exacerbation through B‐cell‐dependent recruitment of inflammatory monocytes. International Forum of Allergy & Rhinology. 2024. doi:10.1002/alr.23426
BibTeX
@article{Waldstein2024,
author = {Waldstein, Kody A and Issimov, Arman and Ganama, Maria and Jinge, Valerie and Tilley, Stephen and Hua, Xiaoyang},
title = {Nasal virus infection induces asthma exacerbation through B‐cell‐dependent recruitment of inflammatory monocytes},
journal = {International Forum of Allergy & Rhinology},
year = {2024},
doi = {10.1002/alr.23426}
}
EUVIMED